MedTrace Logo

Study to Evaluate the Efficacy of Lithium Carbonate in Spinal Cord Injury Patients With Neuropathic Pain

NCT01855594 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-01-28

No results posted yet for this study

Summary

To investigate the efficacy of lithium carbonate in the treatment of neuropathic pain of patients with spinal cord injury.

Conditions

  • Neuropathic Pain
  • Neuralgia
  • Spinal Cord Injuries

Interventions

DRUG

Lithium Carbonate

250 mg/tablet, 6 weeks course of oral administration

DRUG

Placebo

placebo tablet, 6 week course of oral administration

Sponsors & Collaborators

  • China Rehabilitation Research Center

    collaborator OTHER_GOV

  • Second Affiliated Hospital of Xi'an Jiaotong University

    collaborator OTHER

  • China Spinal Cord Injury Network

    lead NETWORK

Principal Investigators

  • Xijing He, M.D. · Xi'an Jiaotong University Second Affiliated Hospital

  • Jianjun Li, M.D. · China Rehabilitaition Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01855594 on ClinicalTrials.gov